Elan in major fundraising move

Pharmaceutical group Elan is to raise approximately $500 million (€390 million) through the issue of senior debt repayable in 2011.

The company will also buy back previously-issued guaranteed notes.

Elan’s debt after the exercise will be just under $2 billion, with half of this falling due in 2008 and the rest in 2011.